← Open Payments lookup

KARL PLEASANT: Open Payments

NPI 1982628145 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,089 in 45 payments from 13 companies in 2025. Trend: 2023 $396 · 2024 $1,213 · 2025 $1,089

Food & beverage: $1,089
CompanyPaymentsAmount
Madrigal Pharmaceuticals5$208
Ardelyx, Inc.11$183
ABBVIE INC.8$158
Janssen Biotech, Inc.1$88
Phathom Pharmaceuticals, Inc.4$68
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$67
PFIZER INC.3$61
Aimmune Therapeutics, Inc.2$53
Takeda Pharmaceuticals U.S.A., Inc.2$51
GENZYME CORPORATION2$49

Products named: REZDIFFRA, IBSRELA, TREMFYA, DUPIXENT, VOQUEZNA, XIFAXAN, LINZESS, RINVOQ.

Industry payments across NC — which companies pay providers there.